Zydus Lifesciences Limited (ZYDUSLIFE) — Financial Results | 11 August 2026
Zydus Lifesciences announced that an audio recording of its investor call discussing unaudited financial results for the quarter ended June 30, 2026, is now available on its website via a provided link.
About Zydus Lifesciences Limited (ZYDUSLIFE)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ZYDUSLIFE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ZYDUSLIFE — Free💡 Ask AI about this filing
📊 More ZYDUSLIFE filings
- Announcement — 12 August 2026 Zydus Lifesciences announced that its scheduled participation in the Motilal Oswal Global Investor C...
- Announcement — 10 August 2026 Zydus Lifesciences announced its participation in the Motilal Oswal 22nd Annual Global Investor Conf...
- Announcement — 10 August 2026 Zydus Lifesciences announced the launch of REVAHALE™, India's first once-daily nebulised LAMA for CO...
- Announcement — 4 August 2026 Zydus Lifesciences announced final USFDA approval for Indocyanine Green for Injection, granting 180-...
- Announcement — 4 August 2026 Zydus Lifesciences announced its participation in the Emkay Confluence 2026 investor conference on A...
🔥 Also filed on 11 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ZYDUSLIFE files new disclosures
Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ZYDUSLIFE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research